Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy : A Randomised, Double-blind, Multicentre, Phase 3b Study (BESIDE)
- Submitting institution
-
University of Bristol
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 93245770
- Type
- D - Journal article
- DOI
-
10.1016/j.eururo.2016.02.030
- Title of journal
- European Urology
- Article number
- -
- First page
- 136
- Volume
- 70
- Issue
- 1
- ISSN
- 0302-2838
- Open access status
- Out of scope for open access requirements
- Month of publication
- March
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
12
- Research group(s)
-
A - Cardiovascular Science
- Citation count
- 89
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
